MedTrace Logo

Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

NCT02446587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-04-16

No results posted yet for this study

Summary

SELECT is a multicenter, observational prospective study implementing a protocol to acquire imaging and clinical variables known to affect clinical outcomes after endovascular therapy in an effort to evaluate and compare the different selection methods and criteria currently used in practice for acute ischemic stroke patients in the anterior circulation with large vessel occlusion. The study aim is to evaluate prospectively different selection methodologies for endovascular therapy, to compare them against each other to identify which method provides the highest predictive ability in the selection of patients for IAT and to devise a formula that predicts patients' outcomes.

This study will enroll patients based on the recent AHA guidelines (July 2015) regarding treatment of patients with acute ischemic strokes and large artery occlusions in the anterior circulation.

Our goal is to collect complete imaging, clinical, and 90 day follow up data on 250 endovascular therapy patients as well as up to 250 concurrent medical management patients as a comparison group.

Conditions

Interventions

DEVICE

Mechanical Thrombectomy

Mechanical thrombectomy includes the use of stent retrievers (i.e. Trevo®, Solitaire®, or other stent retriever devices) as recommended by AHA guidelines (July 2015). A stent retriever is delivered directly to a thromboembolus that is occluding a cerebral artery to restore blood flow.

Sponsors & Collaborators

  • Stryker Neurovascular

    collaborator INDUSTRY

  • WellStar Health System

    collaborator OTHER

  • AdventHealth

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • Riverside Methodist Hospital

    collaborator OTHER

  • Valley Baptist Medical Center

    collaborator UNKNOWN

  • St. Louis University

    collaborator OTHER

  • University of Kansas

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • The University of Texas Health Science Center, Houston

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02446587 on ClinicalTrials.gov